Annovis Bio Inc — Cash Flow (NYSE:ANVS) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities -3.97 M-9.13 M-17.31 M-39.97 M-21.89 M -24.98 M Cash from investing activities ————— — Cash from financing activities 12.04 M46.74 M4 61317.34 M26.69 M 27.63 M Free cash flow -3.97 M-9.13 M-17.31 M-39.97 M-21.89 M -24.98 M

新闻

Annovis Bio将于1月启动长期帕金森病药物研究

Annovis Bio to launch long-term Parkinson’s drug study in January

Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook

Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops

Annovis Bio董事Hoffman以193,794美元购入公司股票

Annovis Bio director Hoffman buys $193,794 in shares

Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling

Annovis Bio董事Hoffman以$69,900购入ANVS股票

Annovis Bio director Hoffman buys $69.9k in ANVS stock

Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)

Annovis Bio’s phase 3 Alzheimer’s trial reaches 25% completion

Annovis Bio raises $3.4 million in registered direct offering